Loading clinical trials...
Loading clinical trials...
The purpose of this study is to show Rotigotine dose response at four doses of Rotigotine used with L-dopa in treating advanced stage Parkinson's disease.
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
UCB Pharma
NCT07330258 · Parkinson's Disease
NCT06508801 · Parkinson's Disease and Parkinsonism
NCT07384429 · Parkinson's Disease, Insomnia, and more
NCT07310264 · Healthy Volunteers (HV), Parkinson's Disease (PD)
NCT02119611 · Parkinson's Disease
Birmingham, Alabama
Tuscaloosa, Alabama
Gilbert, Arizona
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions